Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
35,82 € ↓ -1,80 (-4,78%)
2026-06-05
DEL PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionHighline Wealth Partners Llc
Latest Disclosed Ownership495 shares
Latest Disclosed Value $ 18,191
Highline Wealth Partners Llc reports 9.51% increase in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On April 6, 2026 - Highline Wealth Partners Llc filed a 13F-HR form disclosing ownership of 495 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $15,617 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 452 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of 9.51% during the quarter. The current value of the position is $17,731 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-06 2026-03-31 13F NOVO-NORDISK A S ADR ADR 670100205 495 43 9.51 18 -18.18 0.0046
2026-01-15 2025-12-31 13F NOVO-NORDISK A S ADR ADR 670100205 452 -83 -15.51 23 -24.14 0.0065
2025-10-14 2025-09-30 13F NOVO-NORDISK A S ADR ADR 670100205 535 -9 -1.65 30 -21.62 0.0080
2025-07-16 2025-06-30 13F NOVO-NORDISK A S ADR ADR 670100205 544 -39 -6.69 38 -7.50 0.0111
2025-04-17 2025-03-31 13F NOVO-NORDISK A S ADR ADR 670100205 583 0 0.00 40 -20.00 0.0136
2025-01-10 2024-12-31 13F NOVO-NORDISK A S ADR ADR 670100205 583 -1,810 -75.64 50 -82.39 0.0164
2024-10-25 2024-09-30 13F NOVO-NORDISK A S ADR ADR 670100205 2,393 -64 -2.60 285 -18.86 0.0953
2024-10-28 2024-06-30 13F NOVO-NORDISK A S ADR ADR 670100205 2,457 679 38.19 351 53.51 0.1322
2024-10-28 2024-03-31 13F NOVO-NORDISK A S ADR ADR 670100205 1,778 1,378 344.50 228 456.10 0.0931
2024-10-29 2023-12-31 13F NOVO-NORDISK A S ADR ADR 670100205 400 0 0.00 41 13.89 0.0200
2024-10-29 2023-09-30 13F NOVO-NORDISK A S ADR ADR 670100205 400 400 36 0.0225
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.